Determination of paclitaxel in human plasma using single solvent extraction prior to isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Chromatography B: Biomedical Sciences and Applications

• Publication date

  1998-01-23

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0378-4347(97)00502-1PMID 9498685
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Steady-state plasma concentrations and effects of taxol for a 250 mg/m2 dose in combination with granulocyte-colony stimulating factor in patients with ovarian cancer

  2004cited by this paper
• Sensitive determination of docetaxel in human plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatography.

  1997cited by this paper
• Determination of paclitaxel in biological fluids by micellar electrokinetic chromatography.

  1996cited by this paper
• A convenient tubulin-based quantitative assay for paclitaxel (Taxol) derivatives more effective in inducing assembly than the parent compound

  1996cited by this paper
• Clinical pharmacokinetics and pharmacodynamics of paclitaxel: a 3-hour infusion versus a 24-hour infusion.

  1995cited by this paper
• Isocratic high-performance liquid chromatographic assay of taxol in biological fluids and tissues using automated column switching.

  1995cited by this paper
• Expedient Liquid Chromatographic Assay for Paclitaxel in Plasma After Its Administration to Cancer Patients

  1995cited by this paper
• Isolation, purification, and biological activity of mono- and dihydroxylated paclitaxel metabolites from human feces

  1995cited by this paper
• Quantification of paclitaxel metabolites in human plasma by high-performance liquid chromatography.

  1995cited by this paper
• Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kind.

  1994cited by this paper
• [Determination of new anticancer drug, paclitaxel, in biological fluids by high performance liquid chromatography].

  1994cited by this paper
• High-performance liquid chromatographic procedure for the quantitative determination of paclitaxel (Taxol) in human plasma.

  1993cited by this paper
• An enzyme immunoassay for the determination of taxol and taxanes in Taxus sp. tissues and human plasma.

  1993cited by this paper
• Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients.

  1993cited by this paper
• Characterization of polyclonal and monoclonal anti-taxol antibodies and measurement of taxol in serum.

  1993cited by this paper
• MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring.

  1992cited by this paper
• Analysis of anticancer drugs in biological fluids: determination of taxol with application to clinical pharmacokinetics.

  1990cited by this paper
• High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trial.

  1987cited by this paper
• Phase I clinical and pharmacokinetic study of taxol.

  1987cited by this paper
• Phase I study of taxol administered as a short i.v. infusion daily for 5 days.

  1987cited by this paper
• Tubulin-dependent biochemical assay for the antineoplastic agent taxol and application to measurement of the drug in serum.

  1982cited by this paper
• Taxol stabilizes microtubules in mouse fibroblast cells.

  1980cited by this paper
• Promotion of microtubule assembly in vitro by taxol

  1979cited by this paper
• Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemia and antitumor agent from

  1971cited by this paper
• Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia.

  1971cited by this paper

• A method of isolating and analysing drugs from cancer cells for preclinical research.

  2022cites this paper
• Tissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal Cancer

  2021cites this paper
• The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer Patients

  2021cites this paper
• A novel luminescence sensor based on porous molecularly imprinted polymer-ZnS quantum dots for selective recognition of paclitaxel

  2020cites this paper
• Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours: A Dose-Escalation Study

  2019cites this paper
• Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer

  2018cites this paper
• COF-1-modified magnetic nanoparticles for highly selective and efficient solid-phase microextraction of paclitaxel.

  2017cites this paper
• A Rapid and Sensitive HPLC Method for Quantitation of Paclitaxel in Biological Samples using Liquid-Liquid Extraction and UV Detection: Application to Pharmacokinetics and Tissues Distribution Study of Paclitaxel Loaded Targeted Polymeric Micelles in Tumor Bearing Mice.

  2015cites this paper
• Development and Validation of a Rapid RP-HPLC-DAD Analysis Method for the Simultaneous Quantitation of Paclitaxel and Lapatinib in a Polymeric Micelle Formulation

  2015cites this paper
• A Rapid and Sensitive HPLC Method for Quantitation of Paclitaxel in Biological Samples using Liquid-Liquid Extraction and UV Detection: Application to Pharmacokinetics and Tissues Distribution Study of Paclitaxel Loaded Targeted Polymeric Micelles in.....

  2015cites this paper
• 4β-hydroxycholesterol as an endogenous CYP3A marker in cancer patients treated with taxanes.

  2015cites this paper
• Development of Self-assembled Amphiphilic Oligo-urethanes as Cardiovascular Drug Delivery Platforms

  2015cites this paper
• Highly Selective Electrochemical Determination of Taxol Based on ds-DNA-Modified Pencil Electrode

  2015cites this paper
• Quantification of taxanes in biological matrices: a review of bioanalytical assays and recommendations for development of new assays.

  2014cites this paper
• A Pharmacological Approach to Personalize the Use of Anti-Cancer Drugs

  2013influential citation
• Predictive Biomarkers and Personalized Medicine CYP 3 A 4 22 Genotype and Systemic Exposure Affect Paclitaxel-Induced Neurotoxicity

  2013cites this paper
• CYP3A4*22 Genotype and Systemic Exposure Affect Paclitaxel-Induced Neurotoxicity

  2013cites this paper
• Determination of paclitaxel in hyaluronic acid polymeric micelles in rat blood by protein precipitation-micelle breaking method: application to a pharmacokinetic study.

  2013cites this paper
• Development and Validation of RP-HPLC Method for Analysis of Novel Self-emulsifying Paclitaxel Formulation.

  2013influential citation
• Phase I clinical and pharmacokinetic study of bi-weekly carboplatin/paclitaxel chemotherapy in elderly patients with advanced non-small cell lung cancer.

  2013cites this paper
• A Pharmacogenetic Predictive Model for Paclitaxel Clearance Based on the DMET Platform

  2013cites this paper
• LC-ESI-MS/MS determination of paclitaxel on dried blood spots.

  2012cites this paper
• Drug-Loaded Lipid Nanoparticles for Improved Cancer Treatment: Engineering, In-Vitro, and In-Vivo Evaluation

  2012cites this paper
• Influence of Smoking on the Pharmacokinetics and Toxicity Profiles of Taxane Therapy

  2012cites this paper
• A simple and rapid 3D view method for selective and sensitive determination of paclitaxel in micro volume rat plasma by LC-diode array UV and its application to a pharmacokinetic study.

  2012cites this paper
• A two-step pH-dependent liquid–liquid extraction combined with HPLC-fluorescence method for the determination of 10-hydroxycamptothecin in mouse liver tissue

  2012cites this paper
• Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi’s sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trial

  2011influential citation
• Pharmacokinetic Evaluation of Paclitaxel in South Indian Cancer Patients: A Prospective Study

  2011cites this paper
• Liquid chromatography-tandem mass spectrometry for the determination of paclitaxel in rat plasma after intravenous administration of poly(L-glutamic acid)-alanine-paclitaxel conjugate.

  2010cites this paper
• The therapeutic efficacy of conjugated linoleic acid - paclitaxel on glioma in the rat.

  2010cites this paper
• Development of novel extraction and separation methods for the determination of anthracyclines and taxanes simultaneously from biological matrices

  2010cites this paper
• Chapter 7 Paclitaxel.

  2009cites this paper
• Determination of a novel paclitaxel derivative (NPD-103) in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry.

  2009cites this paper
• A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumors

  2009cites this paper
• Development and validation of a stability-indicating method for the quantitation of Paclitaxel in pharmaceutical dosage forms.

  2009cites this paper
• Simultaneous Determination of Dexamethasone, Dexamethasone 21‐Acetate, and Paclitaxel in a Simulated Biological Matrix by RP‐HPLC: Assay Development and Validation

  2008cites this paper
• In vitro and in vivo studies on plasma-to-blood ratio of paclitaxel in human, rabbit and rat blood fractions.

  2008cites this paper
• A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and oxaliplatin in patients with advanced solid tumors

  2008cites this paper
• Determination of Paclitaxel in Human Plasma by UPLC-MS-MS.

  2008cites this paper
• Determination of paclitaxel in human and rat blood samples after administration of low dose paclitaxel by HPLC-UV detection.

  2007cites this paper
• Simple Analytical Method for the Determination of Paclitaxel (Taxol®) Levels in Human Plasma

  2007cites this paper
• A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumours

  2007cites this paper
• Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese.

  2007cites this paper
• Variants in the SLCO1B3 Gene: Interethnic Distribution and Association with Paclitaxel Pharmacokinetics

  2007cites this paper
• LC‐MS/MS for Determination of Paclitaxel in Rat Tissues: Application to a Biodistribution Study of Paclitaxel Nanoliposome Modified by PEO‐PPO‐PEO Triblock Copolymers

  2006cites this paper
• Impact of the haplotype CYP3A4*16B harboring the Thr185Ser substitution on paclitaxel metabolism in Japanese patients with cancer

  2006cites this paper
• Liquid chromatography/tandem triple-quadrupole mass spectrometry for determination of paclitaxel in rat tissues.

  2006cites this paper
• High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection

  2006cites this paper
• Determination of paclitaxel in rat plasma by LC-MS-MS.

  2006cites this paper
• Determination of Docetaxel and Paclitaxel in Human Plasma by High-Performance Liquid Chromatography: Validation and Application to Clinical Pharmacokinetic Studies

  2006cites this paper
• Quantitative analysis of docetaxel in human plasma using liquid chromatography coupled with tandem mass spectrometry.

  2005cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy 10 Mechanism-Based Pharmacokinetic and Pharmacodynamic Modelling of Paclitaxel

  2005cites this paper
• Sensitive HPLC method for quantitation of paclitaxel (Genexol in biological samples with application to preclinical pharmacokinetics and biodistribution.

  2005cites this paper
• Development and validation of a liquid chromatography-tandem mass spectrometry assay for the quantification of docetaxel and paclitaxel in human plasma and oral fluid.

  2005cites this paper
• Association of CYP 2 C 8 , CYP 3 A 4 , CYP 3 A 5 , and ABCB 1 Polymorphismswith thePharmacokinetics of Paclitaxel

  2005cites this paper
• Mechanism-Based Pharmacokinetic and Pharmacodynamic Modelling of Paclitaxel

  2005cites this paper
• Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 Polymorphisms with the Pharmacokinetics of Paclitaxel

  2005cites this paper
• Comparative in vitro properties and clinical pharmacokinetics of paclitaxel following the administration of Taxol® and Paxene®

  2005cites this paper
• Rapid HPLC method for the determination of paclitaxel in pharmaceutical forms without separation.

  2004cites this paper
• A Phase I and Pharmacokinetic Study of Weekly Paclitaxel and Carboplatin in Patients with Metastatic Esophageal Cancer

  2004cites this paper
• Simple and rapid docetaxel assay in plasma by protein precipitation and high-performance liquid chromatography-tandem mass spectrometry.

  2004cites this paper
• Chapter 2 - Chromatographic methods for the analysis of drugs in biological fluids

  2004cites this paper
• Sensitive liquid chromatography-mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasma.

  2003cites this paper
• Measurement of paclitaxel in biological matrices: high-throughput liquid chromatographic-tandem mass spectrometric quantification of paclitaxel and metabolites in human and dog plasma.

  2003cites this paper
• Effect of valspodar on the pharmacokinetics of unbound paclitaxel

  2003cites this paper
• The Effect of Granisetron on In Vitro Metabolism of Paclitaxel and Docetaxel

  2003cites this paper
• Distribution of paclitaxel in plasma and cerebrospinal fluid

  2003cites this paper
• Altered clearance of unbound paclitaxel in elderly patients with metastatic breast cancer.

  2003cites this paper
• Quantitative determination of paclitaxel in human plasma using semi-automated liquid-liquid extraction in conjunction with liquid chromatography/tandem mass spectrometry.

  2003cites this paper
• A population pharmacokinetic model for paclitaxel in the presence of a novel P-gp modulator, Zosuquidar Trihydrochloride (LY335979).

  2003cites this paper
• Randomized cross-over evaluation of body-surface area-based dosing versus flat-fixed dosing of paclitaxel.

  2003cites this paper
• Randomized C ross-Over E valuation o f B ody-Surface Area-Based D osing V ersus F lat-Fixed D osing o f P aclitaxel

  2003cites this paper
• Quantitation of paclitaxel in micro-sample rat plasma by a sensitive reversed-phase HPLC assay.

  2003cites this paper
• Determination of paclitaxel in mouse plasma and brain tissue by liquid chromatography-mass spectrometry.

  2003cites this paper
• Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel.

  2002cites this paper
• Chapter 23 Sampling and sample preparation for clinical and pharmaceutical analysis

  2002cites this paper
• Determination of the docetaxel vehicle, polysorbate 80, in patient samples by liquid chromatography-tandem mass spectrometry.

  2002cites this paper
• Preclinical evaluation of alternative pharmaceutical delivery vehicles for paclitaxel

  2002cites this paper
• New treatment modalities and pharmacologic refinements for metatstatic breast cancer

  2002cites this paper
• Special problems associated with the bioanalysis of anti-cancer drugs

  2002cites this paper
• Pharmacologic aspects of new classes of anti-cancer agents: inhibitors of topoisomerase I or tubulin

  2001cites this paper
• Mechanism-Based P harmacokinetic M odel f or P aclitaxel

  2001cites this paper
• Mechanism-based pharmacokinetic model for paclitaxel.

  2001cites this paper
• Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles

  2001cites this paper
• Analytical approaches for traditional chinese medicines exhibiting antineoplastic activity.

  2001cites this paper
• High throughput on-line solid phase extraction/tandem mass spectrometric determination of paclitaxel in human serum.

  2000cites this paper
• Pharmaceutical and Biomedical Aspects of Topoisomerase I Inhibitors

  2000cites this paper
• Measurement of Fraction Unbound Paclitaxel in Human Plasma

  2000influential citation
• Rapid and sensitive determination of paclitaxel (Taxol®) in environmental samples by high-performance liquid chromatography tandem mass spectrometry

  2000cites this paper
• Inter-relationships of paclitaxel disposition, infusion duration and Cremophor EL kinetics in cancer patients

  2000cites this paper
• Rapid and sensitive determination of paclitaxel (Taxol(R)) in environmental samples by high-performance liquid chromatography tandem mass spectrometry

  2000cites this paper
• Measurement of fraction unbound paclitaxel in human plasma.

  2000cites this paper
• Rapid and sensitive determination of paclitaxel in mouse plasma by high-performance liquid chromatography.

  1999cites this paper
• Disposition of [G-(3)H]paclitaxel and cremophor EL in a patient with severely impaired renal function.

  1999cites this paper
• Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications.

  1999cites this paper
• Differential modulation of cisplatin accumulation in leukocytes and tumor cell lines by the paclitaxel vehicle Cremophor EL.

  1997cites this paper